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ABSTRAK 
Kajian mengenai kaitan antara kesakitan teruk kronik and ciri personaliti 
neuroticism di kalangan pesakit terapi gantian metadon di Alor Star, Kedah 
Pengenalan: Gejala kesakitan kerap kali didapati di kalangan pesakit gantian metadon, 
dan kajian-kajian telah melaporkan kekerapan kesakitan teruk yang kronik berada pada 
paras 37-48.2%. Gejala tersebut telah menyebabkan ketidakselesaan, kehilangupayaan, 
dan turut menjejaskan kualiti hidup pesakit. Malah, ia juga menjejaskan keberkesanan 
rawatan ketagihan mereka, dan menimbulkan kesangsian pesakit terdahap terapi gantian 
metadon. Pelbagai kajian telah menunjukan kewujudan kaitan di antara ciri personaliti 
neuroticism dan kesakitan teruk kronik secara amnya, namun kewujudan kaitan sebegini 
masih tidak dibuktikan di kalangan pesakit terapi gantian metadon. 
Objektif: Kajian ini bertujuan untuk menilai kekerapan kesakitan teruk kronik di 
kalangan pesakit terapi gantian metadon, serta mengkaji samada wujudnya kaitan antara 
ciri personaliti neuroticism dan kesakitan teruk kronik dalam kumpulan pesakit ini. 
Metodologi: Ini merupakan kajian secara keratan rentas, di mana peserta dinilai dengan 
Brief Pain Inventory (BPI) bagi tahap gejala kesakitan, Big Five Inventory (BFI) untuk 
skor ciri personaliti neuroticism, Beck’s Depression Inventory (BDI) untuk tahap gejala 
kemurungan, dan Beck’s Anxiety Inventory (BAI) untuk tahap gejala keresahan. Saiz 
sampel dikira dengan mengunakan kaedah yang sesuai, dan teknik persampelan universal 
telah digunakan. Kajian ini telah melibatkan dua pusat terapi gantian metadon di Alor 
Star, Kedah.  
Keputusan:  Dengan menggunakan analisa statistik Multiple Logistic Regression, skor 
neuroticism (p<0.001), skor BAI (p=0.012) dan penggunaan ubat tahan sakit “over-the-
counter” (p=0.016) telah didapati berkait dengan signifikannya dengan kesakitan teruk 
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kronik, dengan Odds Ratio masing-masing sebanyak 1.60 (95% CI 1.27, 2.12), 1.44 (95% 
CI 1.08, 1.93) dan 3.56 (95% CI 1.27, 10.01). 
Perbincangan: Skor neuroticism didapati berkait secara positif dengan kesakitan teruk 
kronik di kalangan pesakit terapi gantian metadon, di mana dengan setiap peningkatan 
satu permarkahan skor neuroticism, pesakit mempunyai 60% lebih tinggi kebarangkalian 
untuk mengalami kesakitan teruk kronik. 
Kata-kata kunci: Neuroticism, chronic severe pain, methadone maintenance therapy 
(MMT)  
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ABSTRACT (EXTENDED VERSION) 
The Association between Chronic Severe Pain and Neuroticism Personality Trait 
among Patients on Methadone Maintenance Therapy in Alor Star, Kedah 
Introduction: Pain is very commonly reported among previous heroin users on 
methadone maintenance therapy (MMT) with the prevalence of chronic severe pain (CSP) 
of 37-48.2% being reported. The symptom causes distress and disability, and adversely 
affect patients’ quality of life, addiction treatment outcome and exacerbates their 
ambivalence towards MMT. In general, neuroticism personality trait has been shown by 
various studies to be associated with CSP, but similar association has yet been explored 
in MMT patients.  
Objectives: Current study aim to assess the prevalence of CSP among patients on MMT, 
and to examine whether neuroticism is significantly associated with CSP in this group of 
patients. 
Method: This is a cross-sectional study, utilizing validated Malay versions of Brief Pain 
Inventory (BPI) for pain measurement, Big Five Inventory (BFI) to measure neuroticism, 
Beck’s Depression Inventory (BDI) for measurement of depressive symptoms, and 
Beck’s Anxiety Inventory (BAI) for measurement of anxiety symptoms.  All rating 
instruments mentioned are self-rated instruments. Sample size is determined using proper 
sample size calculation, and universal sampling method is applied for subject recruitment. 
Samples were collected from two MMT centres in Alor Star. 
Results: By using Multiple Logistic Regression analyses, Neuroticism score (p<0.001), 
BAI score (p<0.012) and regular use of over-the-counter analgesics (p<0.016) were found 
to be statistically significant in association with CSP, with adjusted Odds Ratio of 1.60 
(95% CI 1.27, 2.12), 1.44 (95% CI 1.08, 1.93), and 3.56 (95% CI 1.27, 10.01), 
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respectively. Multicollinearity was not detected. However, interaction was noted between 
neuroticism score and BAI score (p=0.028). Hence, the interaction was included into the 
analysis of fitness of final model. The fitness of this final model was confirmed using 
Hosmer-Lemeshow test (p=0.282), classification table (overall correctly classified 
percentage= 83.4%), and area under the receiver operating characteristic (ROC) curve 
test (87.9%). It was interesting to note that the prevalent of daily usage of kratom product 
was over 40% in the sample. 
Discussion: Neuroticism score is positively associated with CSP among patients on 
MMT, whereby with every one point increment in neuroticism score, there is 60% higher 
odds of having CSP. Though it is tempting to conclude that high neuroticism score predict 
CSP development among patient on MMT, the author recognizes the limitations of 
current cross-sectional study design in establishing the nature of the association. Other 
significant associative factors are BAI score and regular use of over-the-counter 
analgesics. For every one point increment in BAI score, there is 44% higher odds of 
patient having CSP; and if an MMT patient use OTC analgesics for at least 3 times a 
week, the odds of having CSP is 3.6 times compared to those not using OTC regularly. 
The results suggest that, firstly, addressing anxiety in patient might help to improve CSP, 
and unaddressed anxiety in patient with chronic pain might in fact adversely affect the 
efficacy of chronic pain intervention and MMT outcome. Besides, the strong association 
between OTC analgesics usage and CSP suggested that when CSP among this group of 
patients was not adequately addressed, patient resorted to OTC analgesics to relieve their 
pain. OTC use as a way of self-medication was reported by studies to be common, and 
the practice actually exposes the patients to adverse drug reactions, which is avoidable. 
In the case of MMT, drug-to-drug interaction of methadone with OTC analgesics could 
be fatal. Over 40% of the study subjects reported use of kratom product daily. Though its 
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association with CSP was not statistically significant, its implication to our MMT patients 
cannot be ignored, as kratom has been increasingly reported locally, as well as globally, 
as an emerging illicit substance with high abuse potential. 
Keywords: Neuroticism, chronic severe pain, methadone maintenance therapy (MMT)  
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CHAPTER 1: INTRODUCTION 
Chronic severe pain among patients on methadone maintenance therapy and its 
implications 
Pain is very commonly reported among previous heroin users on methadone maintenance 
therapy (MMT) with the prevalence of 37-61% (1-5). Chronic severe pain, on the other hand, was 
reported to have prevalence of 37-48.2% (2-4). These findings were rather high as compared to 
prevalence of 10% in general population (6).  
Chronic severe pain (CSP) was reported to be highly problematic, with various 
implications. The implication of pain on people, specifically, patients on MMT is significant. 
Poorly controlled pain, especially chronic pain, has been shown to be associated with disability 
and distress (7), poor addiction outcome (2, 3), and poor quality of life among patients on MMT 
(8). Counselors also reported difficulties in helping patients on MMT with chronic pain (9). 
Chronic severe pain interfered with work and family life, obstructing the fulfillment of social 
obligation, and isolating patients from others. When undertreated, these symptoms can exacerbate 
patients’ anxieties and ambivalence towards MMT (10). 
 
 Neuroticism personality trait and its clinical implications 
 Neuroticism is one of the personality trait in both the three and five factors models of 
personality, also widely known as the Big Three and Big Five theories, respectively (11). 
Traditionally, Eysenck referred to neuroticism as a trait of emotionality, specifically the tendency 
to arouse quickly when stimulated and to inhibit emotions slowly. Costa and McCrae defined 
neuroticism as a dimension of maladjustment or negative emotionality versus adjustment and 
emotional stability (12). Others proposed that facets and correlated adjectives that describe 
neuroticism are Anxiety (tense), Angry hostility (irritable), Depression (not contented), Self-
consciousness (shy), Impulsiveness (moody) and Vulnerability (not self-confident) (13). There 
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were other slightly different definitions by other authors throughout the years, but the differences 
among definitions have been reconciled in the late 1990s with the consensus definition that, at its 
core, neuroticism is the propensity to experience negative emotions (12). 
A person high on neuroticism is prone to experience chronic negative affect, 
psychological distress, and is at increased risk of developing psychopathology and mental illness 
(11, 12, 14-20).  
Pertaining to pathophysiology of pain, neuroticism is being conceived as a vulnerability 
factor in pain perception. It lowers threshold at which pain is perceived as threatening, and at 
which pain catastrophizing emerges. Through structural equation modelling, a study had 
demonstrated that vigilance to pain is associated with heightened pain severity. Besides, it was 
found that pain catastrophizing and pain-related fear mediate the association between neuroticism 
and vigilance to pain (21). 
Others even advocate that neuroticism measurement has the power to predict the 
development of psychopathologies (22, 23). Neuroticism is said to be the single most important 
risk factor in behavioural public health (11). 
When pain catastrophizing and pain coping strategies among subjects on MMT were 
being studied, it was found that subjects in group with CSP reported higher level of pain 
catastrophizing compared to subjects without CSP (24, 25). Addressing pain catastrophizing and 
pain concern among patient on MMT is crucial as this response to pain is associated with adverse 
pain-related clinical outcomes (25). 
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Overview of potential associative factors of chronic severe pain among patients on 
MMT 
 Chronic severe pain in this unique group of patients has been shown, by various studies, 
to be associated with myriad of factors.  
Specific to patient on MMT, significant associations were found between CSP and mental 
illnesses like depression and anxiety disorders (1, 2, 4, 8, 26). Depression and anxiety disorders 
were found to be common among this group of patients (3, 5, 27-29).  
Certain studies attempted to explore the association between CSP and daily dosage of 
methadone being prescribed to patient, and the results were rather inconclusive (3, 5, 30). Other 
studies advocated that long term use of opioids, like methadone, might actually cause opioid-
induced hyperalgesia, where patient become more sensitive to pain perception as compared to 
unexposed individual (30-32). 
On the other hand, it is well reported in various studies that kratom provide analgesic 
effect to people who use it regularly. It exerts its analgesic effect through activity on opioid 
receptors (33, 34). Kratom product was reported being used as opioid substitute by local people 
in countries of Southeast Asia like Thailand and Malaysia (33). However its chronic use leads to 
dependence and withdrawal, with symptoms similar to that of opioid use (35).   
Pain symptoms has been shown to be associated with chronic medical illness (1-3, 5). 
Besides, chronic pain following orthopedic traumatic injuries and fractures were found to be 
common, although the injuries reported in these studies were heterogeneous in terms of nature 
and severity (36-38). Treating chronic pain due to traumatic injury with opioid analgesics had 
been shown to worsen pain symptoms and could lead to other psychopathologies (39). 
It is a global phenomenon that, as a result of intravenous drug use, majority of active 
intravenous drug user (IVDU) or previous IVDU have hepatitis C viral infection, and many of 
them also have hepatitis B virus and HIV infection (40). These infections, especially hepatitis C 
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virus and HIV has been suggested by some studies as a contributing factor in development of 
chronic pain (41-45), although another more recent study suggested otherwise (46). 
From various evidences acquired so far, it is rather safe and reasonable to conclude that 
the determinants of chronic severe pain among MMT patients are likely to be complex.   
 
Rationale of the study 
  Pain is prevalent among subjects on MMT. The symptom not only causes distress, 
impairment and poor quality of life, it also shown to be associated with poor outcomes (2, 3, 7, 
8). The negative effects are expected to be worse if a subject is having chronic severe pain (CSP). 
The symptom is so common that research addressing this symptom and its associated factors is 
helpful in providing more information to guide treating clinician in managing the complaint 
effectively. In view of the prevalence of pain problems in MMT, some authors suggested to 
incorporate comprehensive and structured pain management program into substance abuse 
treatment program (2). 
 In order to manage pain, specifically CSP among this unique population, we need to know 
what factor or psychopathology that is associated to it, if not causing it. The factors considered in 
current study are neuroticism trait, depression and anxiety. Establishing a potential predicting 
factor of pain development, like neuroticism trait, can even help clinician to foresee, and hopefully 
detect the symptom early so that it did not progress into a more chronic, severe or protracted one 
(11). 
 Intravenous drug use has become a major global public health concern due to its 
association with rising of HIV/AIDS epidemic (40). Thus, Malaysian government has been 
paying great attention in the effort of harm reduction (47), thus the expansion of service of MMT 
is expected. This increase in service coverage should ideally be coupled with improvement in 
understanding of the problems faced by the target population so that better quality of service is 
provided to them, as well as the community. After-all, the eventual aim of harm reduction 
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program, of which MMT is part of it, is to create a better community by curbing the rise of 
HIV/AIDS epidemic.  
 Lastly, at the best knowledge of the author, up to the point of preparation of this research 
proposal, there has yet been a study done on CSP among MMT patient locally, especially study 
that taking neuroticism into consideration. Pain perception is a subjective phenomenon, thus what 
has been found in foreign study might not be the case locally. Thus the author believed that the 
study is a worthwhile pursue.  
 In summary, methadone maintenance therapy is an important part of harm reduction 
program in Malaysia (47), and chronic severe pain has been shown by various studies previously 
mentioned to be an important problem that might adversely affect its outcome.  
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CHAPTER 2: OBJECTIVES 
2.1 General Objectives 
 To determine the prevalence of chronic severe pain and level of neuroticism trait among 
subjects on methadone maintenance therapy in Alor Star, Kedah. 
 To determine the association between chronic severe pain and level of neuroticism among 
subjects under study. 
2.2 Specific Objectives 
1. To determine the prevalence of chronic severe pain among subjects on methadone 
maintenance therapy (MMT). 
2. To determine the association between chronic severe pain and socio-demographic and 
clinical characteristics of subjects undergoing MMT in Alor Star.  
3. To determine the association between chronic severe pain and level of neuroticism among 
subjects undergoing MMT. 
 
Research Hypothesis 
Null Hypothesis- there is no difference in score of neuroticism between subjects with CSP and 
those without CSP. 
Alternative Hypothesis- the score of neuroticism is higher among subjects with CSP compared to 
those without CSP. 
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CHAPTER 3: METHODOLOGY 
3.1 Research Design 
This is a cross-sectional study conducted in two methadone maintenance therapy centres in Alor 
Star. The centres are MMT clinic of Department of Psychiatry and Mental Health, Hospital 
Sultanah Bahiyah, Alor Star, and MMT clinic of Klinik Kesihatan Bandar Alor Star. Duration of 
study was from July 2016 till September 2016. 
3.2 Population and Sample 
Reference population: previous heroin users undergoing methadone maintenance therapy. 
Source population: Subjects undergoing methadone maintenance therapy in Department of 
Psychiatry, Hospital Sultanah Bahiyah, Alor Star, and Klinik Kesihatan Bandar Alor Star. 
Sampling Frame 
Universal sampling was applied. All subjects undergoing methadone maintenance therapy who 
satisfied the inclusion and exclusion criteria were recruited into the study. 
3.3 Inclusion and Exclusion Criteria 
Inclusion criteria: 
 Individual age ranged from 18 to 65 years old. 
 Subjects that have been in the therapy for at least one year. This duration is specified 
because pain should present for at least 6 months in order to be defined as chronic. 
Furthermore, the subjects should be stable on adequate dose of methadone before the 
study is conducted on them. 
 Subjects that consented for the study. 
Exclusion criteria: 
 Subject that unable to complete rating instruments due to poor literacy and command in 
Malay Language. 
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3.4 Sample Size Determination  
For the first specific objective, the sample size was calculated using a formula to estimate a 
population proportion with good precision (48-50) 
 n= Z2 [P(1-P)] /d2  
 P is the anticipated prevalence or population proportion. Estimated prevalence of CSP is 
taken as 37% (2, 4). Z value is set at conventional 1.96, for level of confidence of 95%. 
 d is the absolute precision required to calculate sample size. According to Naing and 
colleagues, it is appropriate to have a precision of 5% (to be expressed as d=0.05) if the prevalence 
is expected to fall between 10%-90%. However, the author also suggested that in the case of 
anticipated limitation in resources and time, the precision can be set at higher degree.  
 For current study, limitation in time and resources were expected, hence the d is set at 
7.5% (d=0.075). 
Thus, n = (1.96/0.075)2(0.37)(0.63) = 159 
For the second and third specific objectives, different method of sample size estimation 
was used (51), and the sample size estimated ranged from 67-107, depending on the number of 
significant associative independent variable that is expected out of current study.  
 With the inclusion of potential non-responders of 5%, the final sample size required was 
determined to be 167 subjects. 
3.5 Sampling Method 
Data collection process 
 The subjects undergoing MMT in the study location were approached when they attend 
the clinic for their daily dose of methadone or regular review. For subjects fulfilling inclusion 
criteria, complete patient information sheet were given to them for their reading before consent 
was acquired. Exclusion of subject was done according to exclusion criteria. Consented subjects 
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were then requested to complete a series of questionnaires, including a data form on socio-
demographic and clinical characteristics, Brief Pain Inventory (BPI), Big Five Inventory (BFI), 
Beck’s Depression Inventory (BDI), and Beck’s Anxiety Inventory (BAI). The questionnaires 
were filled up there and then, after they have ingested their methadone of the day. For subjects 
who do not keen to participate, they will be assured that the standard of their MMT in the future 
will not be affected. This is explicitly stated in the patient information sheet to address issue of 
subjects’ vulnerability. 
Measuring instruments  
Socio-demographic and clinical characteristic data form: 
 This questionnaire was self-generated by the author to gather information on age, race, 
gender, marital status, employment status and occupation, level of education ever attained, 
chronic medical illness, presence of mental illness, history of bone fracture, ongoing illicit 
substance use including kratom, current methadone dose, and any self-medication of pain by 
subjects, and duration of MMT since enrolment. 
Brief Pain Inventory (BPI): 
 This is a widely used instrument in clinical pain assessment. It has been used in hundreds 
of studies, and has been shown to be an appropriated measure for pain due to wide range of clinical 
conditions (52). BPI was initially used to measure pain of malignancy, but it has been validated 
for use in study of chronic non-malignant pain as well (53). Tan and colleague demonstrated 
acceptable internal consistency of BPI, with Cronbach alpha coefficients of 0.85 for items of pain 
intensity, and 0.88 for items of pain interference. A validated Malay version of BPI is available 
for use, validated by Aisyaturridha and colleague (54).  
 The questionnaire measures pain at the ‘sensory’ dimension (pain intensity of severity) 
and the ‘reactive’ dimension of pain (interference with daily function). 
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 Under the pain severity dimension, pain is assessed at its ‘worst,’ ‘least,’ ‘average,’ and 
‘now’ (or current pain). For each of the above, subjects will be asked to score at a scale of 0 to 
10, with ‘0’ means ‘no pain’ and ‘10’ means ‘pain as bad as you can imagine’ (52). 
 To measure how the pain has interfered with daily activities, the pain interference 
dimension is then used. For seven daily activities listed in the scale, the subjects will be asked to 
score at the scale of 0 to 10 on how much the pain had interfered with those activities,  with ‘0’ 
means ‘does not interfere’ and ‘10’ means ‘completely interferes’.  Those activities are general 
activity, mood, walking ability, normal work (includes both work outside the home and 
housework), relationships with other people, sleep and enjoyment of life. Mean of the scores of 
seven interference items is used as the overall score, and this mean can be used if four out of the 
seven activities has been rated by a particular subject (52).  
 As an operational definition of chronic severe pain (CSP), current study will adopt the 
definition that has been used by previous studies (2, 4, 10), with some modification.  
 According to Rosenblum et al. and Barry et al., a subject is said to have CSP if he or she 
score 5 or higher on the BPI ‘worst pain’ scale in the past one week, or score 5 or higher on the 
BPI ‘pain interference’ scale. Pain duration should be more than 6 months. Karasz et al. used a 
wider definition, defining CSP as pain lasting longer than six months, with either pain severity or 
pain interference score of 5 or more, without specifying which subscale of pain severity or pain 
interference being referred to.  
 Referring back to the original author of BPI, Cleeland, in his manual he suggested 
researcher to use the mean of the seven interference score as the overall score of pain interference, 
and this mean can be use when at least four out of the seven interference item has been rated.  
 Thus for current study, the following definition of CSP was applied- A subject is said to 
have CSP if he or she score 5 or higher on the BPI ‘worst pain’ scale in the past one week, or 
obtain the mean ‘pain interference’ score of 5 or above, given that at least four out of the seven 
interference scales are scored. Furthermore the pattern of pain should present for at least 6 months. 
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Big Five Inventory (BFI): 
 BFI is a valid and reliable instrument to measure personality traits according to Big Five 
Theory or Five Factor Model of Personality (13, 55).  
 It is an efficient measuring instrument whereby it only takes about 5 minutes to be 
completed, as compared to NEO-FFI that usually take 15 minutes to complete. It was shown to 
be at least as efficient and easily understood as the 60 item NEO-FFI (55). 
 It has good internal consistency, as well as convergent validity with NEO-FFI (55).  
 The inventory consists of 44 items that measure Big Five attributes, ie Neuroticism (8 
items), Extraversion (8 items), Agreeableness (9 items), Conscientiousness (9 items), and 
Openness (10 items). (56). However for current study, only the 8 Neuroticism items will be used 
to measure Neuroticism. 
 Validated Malay version of BFI was used for current study (57). The author of the 
validation study found that Confirmatory Factor Analysis (CFA) had shown sufficient evidence 
to demonstrate the conceptual equivalence between original BFI and Malay version of BFI. It was 
concluded that the results supported the fact that Western based Five Factor Model is valid cross-
culturally in Eastern culture. Translated Malay version of BFI was shown to validly delineate 
personality within Malaysian context. 
 However, by using Hancock and Mueller’s Coefficient H, the study demonstrated 
acceptable reliability (Coefficient H >0.70) for all BFI subscales except Openness to Experience.  
As the author proceeded to examine the validity of translated BFI scales, it was found that because 
of the low reliability of the Openness to Experience, the validity was acceptable only after 
excluding the scale from the original BFI. In other words, the modified translated BFI with only 
scales of Extraversion, Agreeableness, Concientiousness and  Neuroticism showed acceptable 
validity (57).  
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 BFI was chose instead of other available scale like NEO-FFI for current study despite the 
lack of extensive validation of the scale locally (in fact, the above mentioned study was the first 
conducted locally in translating and validating the scale). The use is justified by the fact that the 
scale is shorter, simpler and was shown to be easily understood by subjects answering the 
questionnaire. And because of financial resource limitation in current study, the fact that BFI 
could be used for free in research added more advantage to the use of the scale.      
Beck’s Depression Inventory (BDI): 
 BDI is a well-established self-reported instrument, and has been used by both Western 
and Eastern countries to measure depressive symptoms. It was first created by Aaron T. Beck and 
published more than 50 years ago (58). It has been translated into various languages, and its 
psychometric properties have been evaluated extensively (59, 60).  
 A few studies were carried out to examine the psychometric properties of BDI when being 
used in Malaysian population. Quek and colleagues has validated BDI in a study of patient with 
urological conditions, though in this study, majority of the subjects were Chinese (61). Mukhtar 
and Tian, in their study involving 1090 Malay subject form 4 distinct samples (students, general 
community, general medical patients, and patients with major depressive disorders), they 
concluded that Malay version of BDI is valid for use among Malay subjects in Malaysia, with 
good internal consistency (Cronbach’s alpha ranging from 0.71 to 0.91), and good concurrent and 
discriminant validity (60) 
 Malay version of BDI, as the original version, consists of 21 items indicates various 
symptoms of depression. Subjects are evaluated on how they feel for the past one week. The first 
13 items measure cognitive/affective component, whereas the subsequent 8 items measure 
somatic/performance component(60). Subjects are required to response to each item, indicating 
how severe the particular symptom is. Each item contains 4 responses with the score of 0 to 3. ‘0’ 
indicates the absence of the symptom, whereas ‘3’ indicates severe symptom.  
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 Beck’s Anxiety Inventory (BAI): 
 BAI is an instrument widely used for measurement of severity of anxiety symptoms, 
created by Aaron T. Beck and colleagues (62).  It has been shown to have very good internal 
consistency, with Cronbach’s alpha of 0.92, and high test-retest reliability (62). A Malay version 
of BAI is available and the psychometric properties of this has been examined preliminarily by 
Mukhtar and colleague, with Cronbach’s alpha ranged from 0.66 to 0.89 and overall alpha value 
of 0.91, similar to other previous study done in Western and non-Western country. The concurrent 
validity of the instrument was found to be acceptable (63). 
 BAI consist of 21 questions about how a person feels for the past one week. Those 21 
items are common symptoms of anxiety. The subject tested is required to choose, for each item, 
the severity of related symptom. Each item contains 4 responses with score ranged from 0 to 3, 
with ‘0’ signify no such symptom at all and ‘3’ indicate severe symptom.  
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CHAPTER 4: STATISTICAL ANALYSES 
The data collected were analysed by using IBM SPSS Statistic version 22. The 
association between potential associative factors (numerical and categorical independent 
variables) and the presence of chronic severe pain (dependent variable) were first analysed by 
applying Simple Logistic Regression analysis (SLR). The associative factors with p value< 0.25 
by SLR were then further analysed using Multiple Logistic Regression analysis (MLR). During 
the variable selection processes, forward selection was coupled with backward elimination in 
order to acquire preliminary main effect model. Alpha was set at 0.05. Multicollinearity and 
interaction were checked, and the fitness of the preliminary final model was assessed using 
Hosmer-Lemeshow test, classification table and area under the receiver operating characteristic 
(ROC) curve tests (64). 
 The main objective of the study was to look for association between neuroticism score 
and chronic severe pain, and other factors like BDI score, BAI score, daily methadone dosage and 
other characteristics were included as potential confounders to be controlled for. By using above 
statistical methods, this purpose could be achieved (64-66). 
 
 
 
 
 
 
 
 
 
 
 
 
 
15 
 
CHAPTER 5: MANUSCRIPT 
5.1 Title page:  
The Association between Chronic Severe Pain and Neuroticism Personality Trait 
among Patients on Methadone Maintenance Therapy in Alor Star, Kedah 
 
Author: Chin Hong KOH 
Department of Psychiatry, 
School of Medical Sciences, Universiti Sains Malaysia, 
16150 Kota Bharu, Kelantan. 
 
Corresponding Author: 
Dr Koh Chin Hong 
Corresponding address: 
Department of Psychiatry, School of Medical Sciences,  
Universiti Sains Malaysia,  
16150 Kota Bharu, Kelantan, MALAYSIA. 
Email address:  kohchinhong@yahoo.com 
Telephone: 609-7676710 
Fax:  609-7659057 
 
16 
 
5.2 Abstract 
The Association between Chronic Severe Pain and Neuroticism Personality Trait 
among Patients on Methadone Maintenance Therapy in Alor Star, Kedah 
Introduction: Pain is very commonly reported among previous heroin users on 
methadone maintenance therapy (MMT) with the prevalence of chronic severe pain (CSP) 
of 37-48.2% being reported. The symptom causes distress and disability, and adversely 
affects patients’ quality of life, addiction treatment outcome and exacerbates their 
ambivalence towards MMT. In general, neuroticism personality trait has been shown by 
various studies to be associated with CSP, but similar association has yet been explored 
in MMT patients.  
Objectives: Current study aim to assess the prevalence of CSP among patients on MMT, 
and to examine whether neuroticism is significantly associated with CSP in this group of 
patients. 
Method: This is a cross-sectional study, utilizing validated Malay versions of Brief Pain 
Inventory (BPI) for pain measurement, Big Five Inventory (BFI) to measure neuroticism, 
Beck’s Depression Inventory (BDI) for measurement of depressive symptoms, and 
Beck’s Anxiety Inventory (BAI) for measurement of anxiety symptoms.  All rating 
instruments mentioned are self-rated instruments. Sample size is determined using proper 
sample size calculation, and universal sampling method is applied. Samples were 
collected from two MMT centres in Alor Star. 
Results: Using Multiple Logistic Regression analyses, Neuroticism score (p<0.001), BAI 
score (p=0.012) and regular over-the-counter analgesic use (p=0.016) were found to be 
statistically significant in association with CSP, with adjusted Odds Ratio of 1.60 (95% 
CI 1.27, 2.12), 1.44 (95% CI 1.08, 1.93), and 3.56 (95% CI 1.27, 10.01), respectively. 
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Discussion: Neuroticism score is positively associated with CSP among patients on 
MMT, whereby with every one point increment in neuroticism score, there is 60% higher 
odds of having CSP. Other significant associative factors are BAI score and regular use 
of over-the-counter analgesics. 
Keywords: Neuroticism, chronic severe pain, methadone maintenance therapy (MMT)  
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5.3  Introduction 
Chronic severe pain among patients on methadone maintenance therapy and its 
implications 
Pain is very commonly reported among previous heroin users on methadone 
maintenance therapy (MMT) with the prevalence of 37-61% (1-5). Chronic severe pain, 
on the other hand, was reported to have prevalence of 37-48.2% (2-4).These findings 
were rather high as compared to prevalence of 10% in general population (6).  
Chronic severe pain (CSP) was reported to be highly problematic, with various 
implications. The implication of pain on people, specifically, patients on MMT is 
significant. Poorly controlled pain, especially chronic pain, has been shown to be 
associated with disability and distress (7), poor addiction outcome (2, 3), and poor quality 
of life among patients on MMT (8). Counselors also reported difficulties in helping 
patients on MMT with chronic pain (9). Chronic severe pain interfered with work and 
family life, obstructing the fulfillment of social obligation, and isolating patients from 
others. When undertreated, these symptoms can exacerbate patients’ anxieties and 
ambivalence towards MMT (10). 
 
 Neuroticism personality trait and its clinical implications 
 Neuroticism is one of the personality trait in both the three and five factors models 
of personality, also widely known as the Big Three and Big Five theories, respectively 
(11). Traditionally, Eysenck referred to neuroticism as a trait of emotionality, specifically 
the tendency to arouse quickly when stimulated and to inhibit emotions slowly. Costa and 
McCrae defined neuroticism as a dimension of maladjustment or negative emotionality 
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versus adjustment and emotional stability (12). Others proposed that facets and correlated 
adjectives that describe neuroticism are Anxiety (tense), Angry hostility (irritable), 
Depression (not contented), Self-consciousness (shy), Impulsiveness (moody) and 
Vulnerability (not self-confident) (13). There were other slightly different definitions by 
other authors throughout the years, but the differences among definitions have been 
reconciled in the late 1990s with the consensus definition that, at its core, neuroticism is 
the propensity to experience negative emotions (12). 
A person high on neuroticism is prone to experience chronic negative affect, 
psychological distress, and is at increased risk of developing psychopathology and mental 
illness (11, 12, 14-20).  
Neuroticism is also being conceived as a vulnerability factor in pain perception. 
It lowers threshold at which pain is perceived as threatening, and at which pain 
catastrophizing emerges. Through structural equation modelling, a study had 
demonstrated that vigilance to pain is associated with heightened pain severity. Besides, 
it was found that pain catastrophizing and pain-related fear mediate the association 
between neuroticism and vigilance to pain (21). 
When pain catastrophizing and pain coping strategies among subjects on MMT 
were being studied, it was found that subjects in group with CSP reported higher level of 
pain catastrophizing compared to subjects without CSP (22, 23). Addressing pain 
catastrophizing and pain concern among patient on MMT is crucial as this response to 
pain is associated with adverse pain-related clinical outcomes (23). 
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Overview of potential associative factors of chronic severe pain among patients on 
MMT 
 Chronic severe pain in this unique group of patients has been shown, by various 
studies, to be associated with myriad of factors.  
Specific to patient on MMT, significant associations were found between CSP 
and mental illnesses like depression and anxiety disorders (1, 2, 4, 8, 24). Depression and 
anxiety disorders were found to be common among this group of patients (3, 5, 25-27).  
Certain studies attempted to explore the association between CSP and daily 
dosage of methadone being prescribed to patient, and the results were rather inconclusive 
(3, 5, 28). Other studies advocated that long term use of opioids, like methadone, might 
actually cause opioid-induced hyperalgesia, where patient become more sensitive to pain 
perception as compared to unexposed individual (28-30). 
On the other hand, it is well reported in various studies that kratom provide 
analgesic effect to people who use it regularly. It exerts its analgesic effect through 
activity on opioid receptors (31, 32). Kratom product was reported being used as opioid 
substitute by local people in countries of Southeast Asia like Thailand and Malaysia (31). 
However its chronic use leads to dependence and withdrawal, with symptoms similar to 
that of opioid use (33).   
Pain symptoms has been shown to be associated with chronic medical illness (1-
3, 5). Besides, chronic pain following orthopedic traumatic injuries and fractures were 
found to be common, although the injuries reported in these studies were heterogeneous 
in terms of nature and severity (34-36). Treating chronic pain due to traumatic injury with 
opioid analgesics had been shown to worsen pain symptoms and could lead to other 
psychopathologies (37). 
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It is a global phenomenon that, as a result of intravenous drug use, majority of 
active intravenous drug user (IVDU) or previous IVDU have hepatitis C viral infection, 
and many of them also have hepatitis B virus and HIV infection (38). These infections, 
especially hepatitis C virus and HIV has been suggested by some studies as a contributing 
factor in development of chronic pain (39-43), although another more recent study 
suggested otherwise (44). 
From various evidences acquired so far, it is rather safe and reasonable to 
conclude that the determinants of chronic severe pain among MMT patients are likely to 
be complex.   
 
Rationale of the study and research objectives 
 Methadone maintenance therapy is an important part of harm reduction program 
in Malaysia (45), and chronic severe pain has been show by various studies previously 
mentioned to be an important problem that might adversely affect its outcome.  
Thus, current study aimed to determine the prevalence of chronic severe pain 
among patients on MMT in Alor Star, and further explores whether neuroticism 
personality trait is an associative factor of the distressing symptom. To the author’s best 
knowledge, the postulated association has not yet been adequately and directly explored 
by other researcher. The author hoped that the findings of the study could help in 
improving the service of MMT in the future.  
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5.4  Methodology 
Research design and data sampling 
 This is a cross sectional study, conducted in two centres for methadone 
maintenance therapy (MMT) in Alor Star. Data collection was done from July to 
September 2016. Inclusion and exclusion criteria were applied to screen for eligible 
subjects as they were being approached by researcher in respective methadone clinics.  
For the purpose of determining prevalence of CSP in current study sample, the 
sample size was calculated using a formula to estimate a population proportion with good 
precision (46, 47). 
 n= Z2 [P(1-P)] /d2  
 P is the anticipated prevalence or population proportion. Estimated prevalence of 
CSP is taken as 37% (2, 4). Z value is set at conventional 1.96, for level of confidence of 
95%. d is the absolute precision required to calculate sample size. According to Naing 
and colleagues, it is appropriate to have a precision of 5% (to be expressed as d=0.05) if 
the prevalence is expected to fall between 10%-90%. However, the author also suggested 
that in the case of anticipated limitation in resources and time, the precision can be set at 
higher degree. For current study, the precision was set at 7.5% (d=0.075). 
For the objective of determining the association between neuroticism and CSP, 
different method of sample size estimation was used (48), and the sample size estimated 
ranged from 67-107, depending on the number of significant associative independent 
variable that is expected out of current study.  
The two methods yield the sample size of 159. After included the non-responder 
rate of 5%, total subjects required was 167.  
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Total of 151 samples were successfully collected via universal sampling. It 
consisted of 104 subjects from Klinik Kesihatan Bandar Alor Star (KKBAS), and 47 
subjects from Psychiatric Clinic of Hospital Sultanah Bahiyah. In the author’s opinion, 
as the absolute precision of 7.5% and the power of 0.8 were being used for sample size 
calculation, with no non-responder, the number of sample collected is considered 
adequate. 
 
Inclusion and exclusion criteria 
Inclusion criteria were as follows. 
 Individual age ranged from 18 to 65 years old. 
 Subjects that have been in the therapy for at least 12 months, as pain should 
present for at least 6 months in order to be defined as chronic, and the subjects 
would require time to achieve stable dose of methadone. 
 Subjects that consented for the study. 
Subjects that were unable to complete rating instruments due to poor literacy and 
command in Malay Language were excluded from the study. 
 
Recruitment of subjects 
  A complete patient information sheet was given to subjects that satisfied the 
inclusion and exclusion criteria for their reading, and the study was explained to them 
verbally, before consent being acquired. Consented subjects were requested to complete 
a series of questionnaires, including a data sheet on socio-demographic and clinical 
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characteristics, Brief Pain Inventory (BPI), Big Five Inventory (BFI), Beck’s Depression 
Inventory (BDI), and Beck’s Anxiety Inventory (BAI). 
 Patients who declined the invitation to participate were being assured that the 
standard of their MMT in the future will not be affected. This was explicitly stated in 
patient information sheet to address issue of subjects’ vulnerability. 
 
Rating instruments 
 Data sheets generated by the researcher were used to collect relevant socio-
demographic and clinical data. Other rating instruments were further described below. 
The self-generated data sheets and all the following rating instruments were attached 
under the section of Appendix. 
 Brief Pain Inventory (BPI) 
This is a widely used instrument in clinical pain assessment. It has been used in 
hundreds of studies, and has been shown to be an appropriated measure for pain due to 
wide range of clinical conditions (49). BPI was initially used to measure pain of 
malignancy, but it has been validated for use in study of chronic non-malignant pain as 
well (50). Malay version of BPI was validated by Aisyaturridha and colleague (51)  
 Big Five Inventory (BFI) Neuroticism scale 
BFI is a valid and reliable instrument to measure personality traits according to 
Big Five Theory or Five Factor Model of Personality (13, 52). It is an efficient measuring 
instrument whereby it only takes about 5 minutes to be completed, as compared to NEO-
FFI that usually take 15 minutes to complete. It was shown to be at least as efficient and 
easily understood as the 60 item NEO-FFI. It has good internal consistency, as well as 
